The purpose of this study is to determine whether midodrine administration decreases duration of intravenous vasopressors and intensive care unit length of stay for patients in septic shock.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
duration of intravenous vasopressors
Time frame: from enrollment until discontinuation of intravenous vasopressors, expected to be 3-5 days
intensive care unit length of stay
Time frame: from enrollment until eligible for discharge from intensive care unit, expected to be 4-7 days
re-institution of intravenous vasopressor
Time frame: from enrollment until hospital discharge, expected to be up to 30 days
hospital length of stay
Time frame: from enrollment until hospital discharge, expected to be up to 30 days
mortality
Time frame: from enrollment until hospital discharge, expected to be up to 30 days
midodrine side effects requiring discontinuation
including supine hypertension and bradycardia
Time frame: from enrollment until hospital discharge, expected to be up to 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.